[Form 3] MEI Pharma, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Joshua Riezman, a director of MEI Pharma, Inc. (MEIP), filed an Initial Statement on Form 3 reporting the event date 08/05/2025. The filing states that no securities are beneficially owned by the reporting person. The Form 3 was signed by an attorney-in-fact on 08/20/2025 and includes an Exhibit 24 Power of Attorney.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Riezman Joshua

(Last) (First) (Middle)

9920 PACIFIC HEIGHTS BLVD., SUITE 150

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/05/2025

3. Issuer Name and Ticker or Trading Symbol
MEI Pharma, Inc. [ MEIP ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Justin J. File, as Attorney-in-fact for the Reporting Person	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 filed for MEIP disclose?

The Form 3 discloses that Joshua Riezman, a director, does not beneficially own any securities of MEI Pharma as of the event date 08/05/2025.

Who filed the Form 3 for MEI Pharma (MEIP)?

The Form 3 was filed on behalf of Joshua Riezman; the signature on the filing is by Justin J. File, as Attorney-in-fact dated 08/20/2025.

Does the filing show any derivative or non-derivative holdings?

No. The filing explicitly states "No securities are beneficially owned." There are no entries in Table I or Table II.

Is there a Power of Attorney attached to the Form 3?

Yes. The filing references Exhibit 24 - Power of Attorney, which authorized the attorney-in-fact to sign the form.

What is the event date reported on the Form 3 for MEIP?

The event date listed in the filing is 08/05/2025.